$4550
MARKET OVERVIEW will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Skin pigmentation, or melanin production by specialized cells, determines the color of the skin. The pigment melanin gives the skin, mucous membranes, retina, and hair various hues and tones. People with low melanin deposits have pale skin, whereas those with high melanin deposits have a darker complexion. Pigmentation disorders involve hypopigmentation, hyperpigmentation or depigmentation. Excess melanin production leads to hyperpigmentation, causing dark spots, patches, or discoloration of the skin. The condition can cause an uneven skin tone and alter the color of the skin over time even though hyperpigmentation is very common and quite harmless. Melanin production is easily affected by both internal and environmental influences, which might result in skin pigmentation disorders. Hyperpigmentation disorder can be treated with cosmeceutical, chemical peels, cryotherapy, light or laser therapy, and combination therapy. Furthermore, increased melasma prevalence and awareness of hyperpigmentation treatment is driving the market growth.
MARKET SCOPE
The "Global hyperpigmentation disorder treatment market Analysis to 2030" is a specialized and in-depth study of the pharmaceutical industry with a special focus on global market trend analysis. The report aims to provide an overview of the hyperpigmentation disorder treatment market with detailed market segmentation by treatment type, disease type , end user, and geography. The report provides key statistics on the market status of the leading hyperpigmentation disorder treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The hyperpigmentation disorder treatment market is segmented into treatment type, disease type, end user, and region. Based on treatment type, the global hyperpigmentation disorder treatment market is segmented into cosmeceutical, chemical peels, cryotherapy, light or laser therapy, and others. By disease type, the market is classified into age spots, melasma, post-inflammatory, and others. By end user, the market is categorized into hospitals, dermatology centers, and others.
MARKET DYNAMICS
Drivers-
The global hyperpigmentation disorder treatment market is expanding due to the increased use of nanotechnology in the cosmetics sector to cure hyperpigmentation. Hyperpigmentation is a reasonably common skin condition that can affect anyone with any skin type. The availability of various depigmentation active ingredients for the treatment of skin hyperpigmentation disorders is not completely effective. The ineffectiveness of these products is due to poor permeability through the skin layer and significant toxicity, which causes serious side effects like irritant dermatitis, erythema, itching, and skin flaking. Additionally, nanotechnology substantially contributes to creating cosmeceutical formulations by enhancing active ingredients' solubility, stability, safety, loading efficiency, and skin permeability. Researchers have been looking at how nanotechnology might improve the transport of active chemicals to the skin and their absorption by the body, to improve the effectiveness of certain active agents. Moreover, nanotechnology has become an interesting new development in the beauty industry because of its capacity to enhance the general quality of cosmetic products. Furthermore, the use of nanotechnology enables the capacity to change and enhance properties such as texture, absorption, active ingredient protection, and overall effectiveness of skin. Utilizing depigmentation agents like hydroquinone, arbutin, kojic acid, azelaic acid, and retinoic acid, as well as cutting-edge nanotechnology techniques, may increase the efficacy of hyperpigmentation therapy. With proper skin penetration and minimal systemic absorption, nanotechnology is a viable method for topical hydroquinone delivery to treat hyperpigmentation. This technique lowers the risk of hydroquinone adverse effects and contribute the growth of hyperpigmentation disorder treatment market in the near future.
REGIONAL FRAMEWORK
The report provides a detailed industry overview, including qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides hyperpigmentation disorder treatment market size and forecast estimates from 2020 to 2030 concerning five major regions: North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. Each region's hyperpigmentation disorder treatment market is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally and the current trend and opportunities prevailing in the region. The report analyzes market factors from both the demand and supply sides. Further, it evaluates market dynamics during the forecast period, i.e., drivers, restraints, opportunities, and future trends. The report also provides an exhaustive PEST analysis for all five regions, namely; North America, Europe, APAC, MEA, and South America, after evaluating political, economic, social, and technological factors affecting the hyperpigmentation disorder treatment market in these regions.
North America is anticipated to account for a sizeable portion of the hyperpigmentation disorder treatment market, owing to the increasing prevalence of pigmentation disorders, and a large number of market players offering post-inflammatory hyperpigmentation patients effective treatment options. According to a study, melasma is a hyperpigmentation condition affecting over 5 million Americans. Thus, increasing cases of hyperpigmentation are driving the North America hyperpigmentation treatment disorder market growth.
In addition, the increase in cosmetic procedures also driving the market growth. According to The Aesthetic Surgery Society, surgical procedures increased by 54% in the U.S. alone in 2021. Cosmetic surgery can be one tool to enhance the appearance and correct any flaws and imperfections which make people self-conscious. Hyperpigmentation treatment is one such treatment than can clear the skin and gives the luminous, even skin tone. Furthermore, Asia-Pacific is expected to account for for the largest share of the global hyperpigmentation disorder treatment market. Increasing the adoption of laser treatment for several skin diseases, including hyperpigmentation, and increasing acceptance of pigmentation disorder treatment measures drive the market growth.
Have a question?
Speak to Analyst
The report covers key developments in the hyperpigmentation disorder treatment market as organic and inorganic growth strategies. Various companies such as Aerolase Corporation, Candela Corporation, Cynosure, Galderma S.A, L'Oreal SA, Obagi Cosmeceuticals LLC, PCA Skin, Merz GmbH & Co. KGaA, AbbVie Inc (Allergan, Inc), Pierre Fabre Group and among others are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market players from the hyperpigmentation disorder treatment market are anticipated to have lucrative growth opportunities with the rising demand for Hyperpigmentation Disorder Treatment in the global market.
Key Developments in Global Hyperpigmentation Disorder Treatment Market
- In March 2023, AMBI launched Dark Spot Fade Collection, which includes even & clear fade cream, even & clear fade serum retinol, and the advanced even & clear fade cream. These formulations are hydroquinone-free and are specifically made to help reduce the appearance of dark spots and deliver smooth, even-toned skin.
- In January 2023, Allergan Aesthetics (AbbVie) launched SkinMedica Even & Correct Collection. This product is clinically proven and formulated to deliver targeted results; it helps get an even skin tone and reduces facial hyperpigmentation and dark spots.
- In October 2022, Galderma launched ALASTIN Skincare A-LUMINATE BRIGHTENING SERUM. ALASTIN Skincare lineup is designed to help reduce the appearance of surface hyperpigmentation without any harsh, irritating ingredients.
- In February 2022, Alchemee launched a new hyperpigmentation-focused skincare brand, Restorative Elements. It mainly focuses on helping to correct the appearance of various types of skin hyperpigmentation and discoloration, including age spots, post-inflammatory hyperpigmentation (PIH), sunspots, and uneven skin tone.
The report also includes key companies' profiles, their SWOT analysis, and market strategies in the hyperpigmentation disorder treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information for the last three years, and key development in the past five years.
The Insight Partner's dedicated research and analysis team comprises experienced professionals with advanced statistical expertise and offers various customization options in the current study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Aerolase Corporation
2. Candela Corporation
3. Cynosure
4. Galderma S.A
5. L'Oreal SA
6. Obagi Cosmeceuticals LLC
7. PCA Skin
8. Merz GmbH & Co. KGaA
9. AbbVie Inc (Allergan, Inc)
10. Pierre Fabre Group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Oct 2023
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Oct 2023
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Oct 2023
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)
Oct 2023
Enteral and Parenteral Medical Nutrition Market
Forecast to 2028 - Global Analysis by Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer's Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole–Source), Form (Liquid, Powder, and Semi–Solid), Product Type (General and Disease–Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18–60 Years, 3–18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
Oct 2023
CIN & HR-HPV Treatment Market
Forecast to 2028 - Global Analysis By Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)
Oct 2023
Pharmaceutical Fluid Handling Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Offering (Equipment & Solutions and Services), Tubing (Thermoplastic Elastomers, Polyvinyl Chloride, and Silicone), Application (Fluid Handling & Management, Fluid Preparation, Integration & Automation, Buffer Management, and Others), Usage (Cough Syrup, Intravenous Product, Complex Active Pharmaceutical Ingredients, and Others), and End User (Biotechnology Companies, Pharmaceutical & Medical Companies, and Others)
Oct 2023
Enteral Medical Nutrition Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]
Oct 2023
Glycomic Therapeutics Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]